EP2295448
SCLEROSTIN EPITOPES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.4.2006EP published:
18.1.2017EP application number:
10014372.6
EPO information:
European Patent Register
Max expiry date:
27.4.2026
Title:
SCLEROSTIN EPITOPES
Timeline
Today
28.4.2006EP application
18.1.2017EP Publication
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, 91320-1799, Thousand Oaks, CA, US
Inventor
Name:
Lu, Hsieng SenAddress:
Westlake VillageCalifornia, US
Name:
Paszty, ChristopherAddress:
VenturaCalifornia, US
Name:
Robinson, Martyn KimAddress:
Woodburn GreenBuckinghamshire HP10 0JH, GB
Name:
Henry, Alistair JamesAddress:
UxbridgeMiddlesex UB 8 2LX, GB
Name:
Hoffmann, Kelly SueAddress:
Newbury ParkCalifornia, US
Name:
Latham, JohnAddress:
SeattleWashington, US
Name:
Lawson, AlastairAddress:
SloughBerkshire SL1 3WE, GB
Name:
Winkler, DavidAddress:
ArlingtonMassachusetts, US
Name:
Winters, Aaron GeorgeAddress:
VenturaCalifornia, US
Priority
Number:
677583 PDate:
3.5.2005Country:
US
Number:
776847 PDate:
24.2.2006Country:
US
Number:
782244 PDate:
13.3.2006Country:
US
Number:
792645 PDate:
17.4.2006Country:
US
Number:
410540Date:
25.4.2006Country:
US
Classification
Categories:
A61K 39/00, C07K 16/18, C07K 16/22, C12N 15/63, C07K 14/51